Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adding Liraglutide to High Dose Insulin in Type 2 Diabetes
NCT01505673Phase 4Completed
- Sponsor
- Ildiko Lingvay
- Start
- Jan 2012
- Primary completion
- Jun 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of liraglutide in type 2 diabetes mellitus (T2DM), sponsored by Ildiko Lingvay. Started Jan 2012; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01505673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01505673.